RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1

Acta Oncol. 2015;54(8):1227-9. doi: 10.3109/0284186X.2014.985388. Epub 2014 Dec 31.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Extracellular Matrix Proteins / genetics*
  • GPI-Linked Proteins / genetics
  • Genotype
  • Humans
  • Paclitaxel / adverse effects*
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • Transcription Factors / genetics*

Substances

  • Antineoplastic Agents
  • Extracellular Matrix Proteins
  • GPI-Linked Proteins
  • RWDD3 protein, human
  • TECTA protein, human
  • Transcription Factors
  • Paclitaxel